Summary
This review emphasizes the potential role of lung ultrasound (LUS) as a point-of-care test in Emergency Departments during the COVID-19 pandemic. Molecular tests have limitations in sensitivity and turnaround time, while chest x-ray (CXR) and computed tomography (CT) pose challenges in diagnostic efficiency.
LUS, however, is quick, repeatable, and may aid in decision-making for patients with respiratory symptoms. The article discusses indications for LUS, typical sonographic abnormalities in COVID-19, and recommendations for performing LUS, including infection control measures.
The authors stress the importance of a structured framework governing education, quality assurance, and proctored scanning protocols for the effective use of LUS during the pandemic.
